HomeCompareHOLX vs MPLX

HOLX vs MPLX: Dividend Comparison 2026

HOLX yields 2.65% · MPLX yields 7.47%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MPLX wins by $427.1K in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
MPLX
MPLX
● Live price
7.47%
Share price
$57.67
Annual div
$4.31
5Y div CAGR
38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$450.7K
Annual income
$220,593.13
Full MPLX calculator →

Portfolio growth — HOLX vs MPLX

📍 MPLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXMPLX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + MPLX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
MPLX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
MPLX
Annual income on $10K today (after 15% tax)
$635.25/yr
After 10yr DRIP, annual income (after tax)
$187,504.16/yr
At 15% tax rate, MPLX beats the other by $187,237.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + MPLX for your $10,000?

HOLX: 50%MPLX: 50%
100% MPLX50/50100% HOLX
Portfolio after 10yr
$237.2K
Annual income
$110,453.57/yr
Blended yield
46.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MPLX right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
MPLX
Analyst Ratings
19
Buy
9
Hold
Consensus: Buy
Price Target
$59.50
+3.2% upside vs current
Range: $59.00 — $60.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
MPLX buys
0
No recent congressional trades found for HOLX or MPLX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXMPLX
Forward yield2.65%7.47%
Annual dividend / share$2.00$4.31
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%38.1%
Portfolio after 10y$23.6K$450.7K
Annual income after 10y$314.03$220,593.13
Total dividends collected$2.9K$402.2K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$77.80$59.50

Year-by-year: HOLX vs MPLX ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrMPLX PortfolioMPLX Income/yrGap
1← crossover$10,965$264.73$11,732$1,032.10$767.00MPLX
2$12,004$271.27$14,116$1,562.81$2.1KMPLX
3$13,121$277.55$17,531$2,426.93$4.4KMPLX
4$14,323$283.54$22,649$3,890.12$8.3KMPLX
5$15,615$289.27$30,720$6,486.35$15.1KMPLX
6$17,003$294.73$44,226$11,355.22$27.2KMPLX
7$18,493$299.93$68,420$21,098.77$49.9KMPLX
8$20,093$304.87$115,338$42,128.55$95.2KMPLX
9$21,809$309.57$215,071$91,658.85$193.3KMPLX
10$23,649$314.03$450,719$220,593.13$427.1KMPLX

HOLX vs MPLX: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

MPLXEnergy

MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Logistics and Storage, and Gathering and Processing. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, exchange, storage, and marketing of natural gas liquids; gathering, storage, transportation, and distribution of crude oil and refined products, as well as other hydrocarbon-based products; and sale of residue gas and condensate. It also engages in the inland marine businesses comprising transportation of light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks in the Mid-Continent and Gulf Coast regions, as well as owns and operates boats and barges, including third-party chartered equipment, and a marine repair facility located on the Ohio River; and distribution of fuel, as well as operates refining logistics, terminals, rail facilities, and storage caverns. In addition, the company operates terminal facilities for the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products located through the pipeline, rail, marine, and over-the-road modes of transportation. MPLX GP LLC acts as the general partner of MPLX LP. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP operates as a subsidiary of Marathon Petroleum Corporation.

Full MPLX Calculator →
📬

Get this HOLX vs MPLX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.